Editor’s Note: This roundup is meant to highlight some of the most notable funding rounds of the month and is not intended to be comprehensive.
Health tech companies made several major funding announcements in December. Here is a list of some of the biggest funding rounds.
Curative secures $150 million in Series B funding
Curative, based in Austin, Texas, offers an employer-based health plan with $0 out-of-pocket costs, including no co-pays, no deductibles and no coinsurance. Members just have to complete an annual preventative health visit in order to obtain the $0 out-of-pocket costs.
The Series B funding was led by TED Chairman Chris Anderson’s Upside Vision Fund and included participation from Justin Mateen, founder of JAM Fund. Additional investors include Mike Novogratz of Galaxy Digital, Stanley Druckenmiller’s Duquesne Family Office, DCVC and Martin Varsavsky. The financing will help scale Curative’s business nationally, according to the announcement.
Angle Health raises $134 million in Series B funding
San Francisco-based Angle Health is a digital healthcare benefits provider for employers. Its AI-powered app offers care navigation services through its care team. Its customizable health plans include telemedicine, behavioral health and other digital health solutions. The company can also help with payment processing, billing and invoicing, and serves more than 3,000 employers across 44 states.
Angle Health’s Series B round was led by Portage and included participation from Blumberg Capital, Mighty Capital, PruVen Capital, SixThirty Ventures, TSVC, Wing VC and Y Combinator. The round included a combination of debt and equity. In total, Angle Health has raised about $200 million.
Paradigm Health rakes in $78 million in Series B funding
Paradigm Health offers an AI-powered platform that aims to provide equitable access to clinical trials for patients. The platform automates patient matching with clinical trials and helps health systems accrue eligible patients for trials.
The funding was led by ARCH Venture Partners, with participation from DFJ Growth, F-Prime, General Catalyst, GV, Lux Capital, Mubadala Capital and the American Cancer Society’s BrightEdge Fund. The financing “will be used to accelerate Paradigm Health’s expansion as demand grows from global biopharmaceutical companies for more efficient trials and from health systems seeking to offer trials to patients closer to where they receive routine care,” according to the announcement.
Artera raises $65 million in funding
Santa Barbara, California-based Artera is a healthcare technology company that leverages AI to help providers communicate more easily with patients. Its platform uses automated text, voice and web messaging to handle things like appointment scheduling, intake and billing.
The funding included support from Lead Edge Capital, Jackson Square Ventures, Health Velocity Capital, Heritage Medical Systems and Summation Health Ventures. It will help Artera further grow its company and adopt agentic AI in healthcare.
Photo: Abscent84, Getty Images
